Overview

* IFF Q3 sales decline 8% yr/yr but beat analyst expectations

* Company reaffirms full-year 2025 financial guidance despite challenging environment

Outlook

* IFF maintains full-year 2025 sales guidance of $10.6 bln to $10.9 bln

* IFF expects 2025 adjusted operating EBITDA of $2 bln to $2.15 bln

* IFF anticipates 1%-4% comparable currency neutral sales growth, lower end expected

* Foreign exchange expected to reduce 2025 sales growth by ~1%

* Pharma Solutions divestiture to impact 2025 sales growth by ~7%

Result Drivers

* SCENT AND TASTE - Sales momentum in Scent and Taste segments supported by strong new win contributions

* PRODUCTIVITY GAINS - Margin expansion driven by productivity improvements, according to CEO Erik Fyrwald

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Beat $2.69 $2.63

bln bln (11

Analysts

)

Q3 EPS $0.16

Q3 Net $41 mln

Income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 15 "strong buy" or "buy", 5 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the food processing peer group is "buy"

* Wall Street's median 12-month price target for International Flavors & Fragrances Inc ( IFF ) is $80.00, about 22.4% above its November 3 closing price of $62.08

* The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 16 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)